| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 June 2002 | Volume 136 Issue 11 | Pages 792-801
Purpose: Bloodstream infections related to use of catheters, particularly central-line catheters, are an important cause of patient morbidity, mortality, and increased health care costs. This study evaluated the efficacy of skin disinfection with chlorhexidine gluconate compared with povidone-iodine solution in preventing catheter-related bloodstream infection.
Data Sources: Multiple computerized databases (1966 to 2001), reference lists of identified articles, and queries of principal investigators and antiseptic manufacturers.
Study Selection: Randomized, controlled trials comparing chlorhexidine gluconate with povidone-iodine solutions for catheter-site care.
Data Extraction: Using a standardized form, two reviewers abstracted data on study design, patient population, intervention, and incidence of catheter-related bloodstream infection from all included studies.
Data Synthesis: Eight studies involving a total of 4143 catheters met the inclusion criteria. All studies were conducted in a hospital setting, and various catheter types were used. The summary risk ratio for catheter-related bloodstream infection was 0.49 (95% CI, 0.28 to 0.88) in patients whose catheter sites were disinfected with chlorhexidine gluconate instead of povidone-iodine. Among patients with a central vascular catheter, chlorhexidine gluconate reduced the risk for catheter-related bloodstream infection by 49% (risk ratio, 0.51 [CI, 0.27 to 0.97]).
Conclusions: These results suggest that incidence of bloodstream infections is significantly reduced in patients with central vascular lines who receive chlorhexidine gluconate versus povidone-iodine for insertion-site skin disinfection. Use of chlorhexidine gluconate is a simple and effective means of reducing vascular catheterrelated infections.
Editors' Notes
Context
Contribution
Implications
The Editors
Author and Article Information
From Naresuan University, Pitsanuloak, Thailand; University of Washington and Veterans Affairs Puget Sound Healthcare System, Seattle, Washington; and University of Michigan and Ann Arbor Veterans Administration Medical Center, Ann Arbor, Michigan.
Acknowledgments: The authors thank Gerard Sheehan, MD, John M. Conly, MD, Raphaele Girard, MD, Angela LeBlanc, BSc (Hed), and Valerie Knasinski, RN, for providing citations of additional studies or additional information from their studies. They also thank Todd A. Lee, PharmD, PhD, for helping with the abstraction of these studies.
Requests for Single Reprints: David L. Veenstra, PharmD, PhD, Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, Box 357630, University of Washington, Seattle, WA 98195-7630; e-mail, veenstra{at}u.washington.edu.
Current Author Addresses: Dr. Chaiyakunapruk: Department of Pharmacy Practice, School of Pharmacy, Naresuan University, Pitsanuloak 65000, Thailand.
Dr. Veenstra: Pharmaceutical Outcomes Research and Policy Program, Box 357630, University of Washington, Seattle, WA 98195-7630.
Dr. Lipsky: Veterans Affairs Puget Sound Health Care System (S-111-GIMC), 1660 South Columbian Way, Seattle, WA 98108-1597.
Dr. Saint: University of Michigan Medical School, Room 7E08, 300 NIB, Campus Box 0429, Ann Arbor, MI 48109-0429.
Author Contributions: Conception and design: D.L. Veenstra, S. Saint.
Analysis and interpretation of the data: N. Chaiyakunapruk, D.L. Veenstra, B.A. Lipsky, S. Saint.
Drafting of the article: N. Chaiyakunapruk, B.A. Lipsky.
Critical revision of the article for important intellectual content: N. Chaiyakunapruk, D.L. Veenstra, B.A. Lipsky, S. Saint.
Final approval of the article: N. Chaiyakunapruk, D.L. Veenstra, B.A. Lipsky, S. Saint.
Statistical expertise: N. Chaiyakunapruk, D.L. Veenstra.
Obtaining of funding: D.L. Veenstra, S. Saint.
Administrative, technical, or logistic support: N. Chaiyakunapruk.
Collection and assembly of data: N. Chaiyakunapruk. ARTICLE
Chlorhexidine Compared with Povidone-Iodine Solution for Vascular CatheterSite Care
A Meta-Analysis
![]()
![]()
Related articles in Annals:
This article has been cited by other articles:
![]() |
J. M. Costello, D. F. Morrow, D. A. Graham, G. Potter-Bynoe, T. J. Sandora, and P. C. Laussen Systematic Intervention to Reduce Central Line-Associated Bloodstream Infection Rates in a Pediatric Cardiac Intensive Care Unit Pediatrics, May 1, 2008; 121(5): 915 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Mimoz, S. Villeminey, S. Ragot, C. Dahyot-Fizelier, L. Laksiri, F. Petitpas, and B. Debaene Chlorhexidine-Based Antiseptic Solution vs Alcohol-Based Povidone-Iodine for Central Venous Catheter Care Arch Intern Med, October 22, 2007; 167(19): 2066 - 2072. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Pildal, A Hrobjartsson, K. Jorgensen, J Hilden, D. Altman, and P. Gotzsche Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials Int. J. Epidemiol., August 1, 2007; 36(4): 847 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Falagas, K. Fragoulis, I. A. Bliziotis, and I. Chatzinikolaou Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials J. Antimicrob. Chemother., March 1, 2007; 59(3): 359 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Cummings and J. A. Dolak Case report: Epidural abscess in a parturient with pruritic urticarial papules and plaques of pregnancy (PUPPP): [Presentation de cas : un abces peridural chez une parturiente qui presente des papules et des plaques prurigineuses urticariennes de la grossesse (PPPUG)]. Can J Anesth, October 1, 2006; 53(10): 1010 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Ho and E. Litton Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis J. Antimicrob. Chemother., August 1, 2006; 58(2): 281 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Grewal, G. Hocking, and J. A. W. Wildsmith Epidural abscesses Br. J. Anaesth., March 1, 2006; 96(3): 292 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Banton Techniques to Prevent Central Venous Catheter Infections: Products, Research, and Recommendations Nutr Clin Pract, February 1, 2006; 21(1): 56 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Rupp, S. J. Lisco, P. A. Lipsett, T. M. Perl, K. Keating, J. M. Civetta, L. A. Mermel, D. Lee, E. P. Dellinger, M. Donahoe, et al. Effect of a Second-Generation Venous Catheter Impregnated with Chlorhexidine and Silver Sulfadiazine on Central Catheter-Related Infections: A Randomized, Controlled Trial Ann Intern Med, October 18, 2005; 143(8): 570 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Haase, K. A. McCracken, and R. L. Akins Catheter-Related Bloodstream Infections in the Intensive Care Unit Population Journal of Pharmacy Practice, February 1, 2005; 18(1): 42 - 52. [Abstract] [PDF] |
||||
![]() |
C.M. Pellowe, R.J. Pratt, H.P. Loveday, P. Harper, N. Robinson, and S.R.L.J. Jones The epic project. Updating the evidence-base for national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England: a report with recommendations Journal of Infection Prevention, December 1, 2004; 5(6): 10 - 16. [Abstract] [PDF] |
||||
![]() |
L. Rubinson, E. F. Haponik, A. W. Wu, and G. B. Diette Internists' Adherence to Guidelines for Prevention of Intravascular Catheter Infections JAMA, December 3, 2003; 290(21): 2802 - 2802. [Full Text] [PDF] |
||||
![]() |
R. C. Prielipp and R. J. Sherertz Skin: The First Battlefield Anesth. Analg., October 1, 2003; 97(4): 933 - 935. [Full Text] [PDF] |
||||
![]() |
I. El-Hamamsy, N. Durrleman, L.-M. Stevens, T. K. Leung, S. Theoret, M. Carrier, and L. P. Perrault Incidence and outcome of radial artery infections following cardiac surgery Ann. Thorac. Surg., September 1, 2003; 76(3): 801 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Shorr, C. W. Humphreys, and D. L. Helman New Choices for Central Venous Catheters: Potential Financial Implications Chest, July 1, 2003; 124(1): 275 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D Krau Review: chlorhexidine gluconate is more effective than povidone-iodine for preventing vascular catheter related bloodstream infection Evid. Based Nurs., January 1, 2003; 6(1): 18 - 18. [Full Text] [PDF] |
||||
![]() |
C. E. Lok, K. E. Stanley, J. E. Hux, R. Richardson, S. W. Tobe, and J. Conly Hemodialysis Infection Prevention with Polysporin Ointment J. Am. Soc. Nephrol., January 1, 2003; 14(1): 169 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Garland, K. Henrickson, and D. G. Maki The 2002 Hospital Infection Control Practices Advisory Committee Centers for Disease Control and Prevention Guideline for Prevention of Intravascular Device-Related Infection Pediatrics, November 1, 2002; 110(5): 1009 - 1013. [Full Text] [PDF] |
||||
![]() |
Use Chlorhexidine for Vascular Catheter-Site Care Journal Watch (General), June 18, 2002; 2002(618): 2 - 2. [Full Text] |
||||